WHO ICTRP trial
Does subcutaneous interleukin-1 receptor antagonist reduce inflammation…
EUCTR2011-001855-35-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-001855-35-GB |
|---|---|
| Public title | Does subcutaneous interleukin-1 receptor antagonist reduce inflammation following subarachnoid haemorrhage? - SC IL-1Ra in SAH |
| Scientific title | Does subcutaneous interleukin-1 receptor antagonist reduce inflammation following subarachnoid haemorrhage? - SC IL-1Ra in SAH |
| Primary sponsor | Salford Royal NHS Foundation Trust |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Subarachnoid haemorrhage MedDRA version: 14.0 Level: PT Classification code 10042316 Term: Subarachnoid haemorrhage System Organ Class: 10029205 - Nervous system disorders |
| Interventions | Trade Name: Kineret (anakinra) Product Name: Kineret Product Code: L04AA14 Pharmaceutical Form: Solution for injection INN or Proposed INN: Anakinra CAS Number: 143090920 Other descriptive name: Kineret Concentration unit: mg milligram(s)… |
| Registration date | Jun 23, 2011 |
| Target size | 140 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: